Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
Lee
W J
WJ
Baxter Healthcare Corporation, Round Lake, Illinois.
Zimmerman
T
T
Meyers
S
S
Bender
J G
JG
Williams
S F
SF
D015703:Antigens, CD / Q000378:metabolism; D018952:Antigens, CD34; D001772:Blood Cell Count; D001773:Blood Cells / Q000166:cytology* / Q000187:drug effects* / Q000276:immunology; D001781:Blood Component Removal; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy / Q000628:therapy; D003114:Colony-Forming Units Assay; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects* / Q000276:immunology; D006689:Hodgkin Disease / Q000097:blood / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000188:drug therapy / Q000628:therapy; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000628:therapy*; D013997:Time Factors; D014182:Transplantation, Autologous
D015703:Antigens, CD; D018952:Antigens, CD34; D016179:Granulocyte Colony-Stimulating Factor; D003520:Cyclophosphamide